These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2122936)

  • 1. Soluble HLA class I antigen secretion by normal lymphocytes: relationship with cell activation and effect of interferon-gamma.
    Brieva JA; Villar LM; Leoro G; Alvarez-Cermeño JC; Roldán E; Gonzalez-Porqué P
    Clin Exp Immunol; 1990 Nov; 82(2):390-5. PubMed ID: 2122936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.
    Puppo F; Contini P; Ghio M; Indiveri F
    ScientificWorldJournal; 2002 Feb; 2():421-3. PubMed ID: 12806026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
    Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
    Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metalloproteinase-mediated pathway is essential for generation of soluble HLA class I proteins by activated cells in vitro: proposed mechanism for soluble HLA release in transplant rejection.
    DeVito-Haynes LD; Demaria S; Bushkin Y; Burlingham WJ
    Hum Immunol; 1998 Jul; 59(7):426-34. PubMed ID: 9684992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of soluble class I molecules (non HLA-A or HLA-B) in serum, spleen membranes and lymphocytes in culture.
    Villar LM; Roy G; Lázaro I; Alvarez-Cermeno JC; González M; Brieva JA; Del la Sen ML; Leoro G; Bootello A; González-Porqué P
    Eur J Immunol; 1989 Oct; 19(10):1835-9. PubMed ID: 2583224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes.
    Puppo F; Contini P; Ghio M; Brenci S; Scudeletti M; Filaci G; Ferrone S; Indiveri F
    Int Immunol; 2000 Feb; 12(2):195-203. PubMed ID: 10653855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of soluble HLA-class-I molecules by IFN-gamma-induced colon-adenocarcinoma cells.
    Le J; Hua JC
    Int J Cancer; 1995 Feb; 60(4):576-81. PubMed ID: 7829274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A subclass of soluble HLA-G1 modulates the release of cytokines from mononuclear cells present in the decidua additively to membrane-bound HLA-G1.
    Kanai T; Fujii T; Kozuma S; Miki A; Yamashita T; Hyodo H; Unno N; Yoshida S; Taketani Y
    J Reprod Immunol; 2003 Dec; 60(2):85-96. PubMed ID: 14638437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells.
    van der Meer A; Lukassen HG; van Cranenbroek B; Weiss EH; Braat DD; van Lierop MJ; Joosten I
    Mol Hum Reprod; 2007 Feb; 13(2):123-33. PubMed ID: 17121749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effects of solubilized HLA-DR--role in immunoregulation?
    Claus R; Hausmann S; Zavazava N; Walzel H; Schulze HA; Köhler H; Friemel H; Müller-Ruchholtz W
    Cell Immunol; 1994 May; 155(2):476-85. PubMed ID: 8181077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma production in human NK cells through the engagement of CD8 by soluble or surface HLA class I molecules.
    Spaggiari GM; Contini P; Negrini S; Dondero A; Carosio R; Ghio M; Puppo F; Indiveri F; Zocchi MR; Poggi A
    Eur J Immunol; 2003 Nov; 33(11):3049-59. PubMed ID: 14579273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis.
    Ciprandi G; Continia P; Fenoglio D; Sormani MP; Negrini S; Puppo F; Indiveri F
    Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders.
    Sebti Y; Le Maux A; Gros F; De Guibert S; Pangault C; Rouas-Freiss N; Bernard M; Amiot L
    Br J Haematol; 2007 Jul; 138(2):202-12. PubMed ID: 17593027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004.
    Rebmann V; Lemaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
    Hum Immunol; 2005 Aug; 66(8):853-63. PubMed ID: 16216668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble HLA-G molecules are increased in lymphoproliferative disorders.
    Sebti Y; Le Friec G; Pangault C; Gros F; Drénou B; Guilloux V; Bernard M; Lamy T; Fauchet R; Amiot L
    Hum Immunol; 2003 Nov; 64(11):1093-101. PubMed ID: 14602240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release.
    Morandi F; Levreri I; Bocca P; Galleni B; Raffaghello L; Ferrone S; Prigione I; Pistoia V
    Cancer Res; 2007 Jul; 67(13):6433-41. PubMed ID: 17616704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma drives the metalloproteinase-dependent cleavage of HLA class I soluble forms from primary human bronchial epithelial cells.
    Haynes LD; Bushkin Y; Love RB; Burlingham WJ
    Hum Immunol; 2002 Oct; 63(10):893-901. PubMed ID: 12368042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-classic sHLA class I in human oocyte culture medium.
    Menicucci A; Noci I; Fuzzi B; Criscuoli L; Scarselli G; Baricordi O; Mattiuz PL
    Hum Immunol; 1999 Nov; 60(11):1054-7. PubMed ID: 10600002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.